H. R. 7776—946 
shall be charged to the recipient notwithstanding section 516(e) 
of the Foreign Assistance Act of 1961 (22 U.S.C. 2321j(e)). 
(e) REPAIR
AND REFURBISHMENT
IN UNITED STATES SHIP-
YARDS.—To the maximum extent practicable, the President shall 
require, as a condition of the transfer of a vessel under this section, 
that the recipient to which the vessel is transferred have such 
repair or refurbishment of the vessel as is needed, before the 
vessel joins the naval forces of that recipient, performed at a ship-
yard located in the United States. 
(f) EXPIRATION
OF AUTHORITY.—The authority to transfer a 
vessel under this section shall expire at the end of the 3-year 
period beginning on the date of the enactment of this Act. 
SEC. 5549. REPORTING REQUIREMENTS. 
(a) SECRETARY OF STATE.—The Secretary of State, in coordina-
tion with the heads of other relevant Federal departments and 
agencies as described in sections 5543, 5545, and 5546(a), shall— 
(1) not later than 180 days after the date of the enactment 
of this Act, submit to the appropriate congressional committees 
a comprehensive strategy to address the requirements described 
in sections 5543, 5545, and 5546(a); and 
(2) not later than 2 years and 4 years after submitting 
the comprehensive strategy under paragraph (1), submit to 
the appropriate congressional committees a report describing 
the implementation of the strategy. 
(b) ADMINISTRATOR OF THE UNITED STATES AGENCY FOR INTER-
NATIONAL DEVELOPMENT.—The Administrator of the United States 
Agency for International Development, in coordination with the 
heads of other relevant Federal departments and agencies as 
described in sections 5544, 5546(b), and 5547, shall— 
(1) not later than 180 days after the date of the enactment 
of this Act, submit to appropriate congressional committees 
a comprehensive strategy to address the requirements described 
in sections 5544, 5546(b) and 5547; and 
(2) not later than 2 years and 4 years after submitting 
the comprehensive strategy under paragraph (1), submit to 
the appropriate congressional committees a report describing 
the implementation of the strategy. 
(c) SUBMISSION.—The strategies and reports required under 
subsections (a) and (b) may be submitted to the appropriate congres-
sional committees as joint strategies and reports. 
(d) APPROPRIATE CONGRESSIONAL COMMITTEES.—In this sub-
title, the term ‘‘appropriate congressional committees’’ means the 
Committee on Foreign Relations of the Senate and the Committee 
on Foreign Affairs and the Committee on Energy and Commerce 
of the House of Representatives. 
SEC. 5550. SUNSET. 
This subtitle shall terminate on the date that is 5 years after 
the date of the enactment of this Act. 
Subtitle C—FENTANYL Results Act 
SEC. 5551. SHORT TITLE. 
This subtitle may be cited as the ‘‘Fighting Emerging Narcotics 
Through Additional Nations to Yield Lasting Results Act’’ or the 
‘‘FENTANYL Results Act’’.
H. R. 7776—947 
SEC. 5552. PRIORITIZATION OF EFFORTS OF THE DEPARTMENT OF 
STATE TO COMBAT INTERNATIONAL TRAFFICKING IN 
COVERED SYNTHETIC DRUGS. 
(a) IN GENERAL.—The Secretary of State shall prioritize efforts 
of the Department of State to combat international trafficking of 
covered synthetic drugs by carrying out programs and activities 
to include the following: 
(1) Supporting increased data collection by the United 
States and foreign countries through increased drug use surveys 
among populations, increased use of wastewater testing where 
appropriate, and multilateral sharing of that data. 
(2) Engaging in increased consultation and partnership 
with international drug agencies, including the European Moni-
toring Centre for Drugs and Drug Addiction, regulatory agen-
cies in foreign countries, and the United Nations Office on 
Drugs and Crime. 
(3) Carrying out programs to provide technical assistance 
and equipment, as appropriate, to strengthen the capacity of 
foreign law enforcement agencies with respect to covered syn-
thetic drugs, as required by section 5553. 
(4) Carrying out exchange programs for governmental and 
nongovernmental personnel in the United States and in foreign 
countries to provide educational and professional development 
on demand reduction matters relating to the illicit use of cov-
ered synthetic drugs and other drugs, as required by section 
5554. 
(b) REPORT.— 
(1) IN GENERAL.—Not later than one year after the date 
of the enactment of this Act, the Secretary of State shall submit 
to the appropriate congressional committees a report on the 
implementation of this section. 
(2) APPROPRIATE CONGRESSIONAL COMMITTEES DEFINED.— 
In this subsection, the term ‘‘appropriate congressional commit-
tees’’ means— 
(A) the Committee on Foreign Relations, the Com-
mittee on Appropriations, and the Committee on the 
Judiciary of the Senate; and 
(B) the Committee on Foreign Affairs, the Committee 
on Appropriations, and the Committee on the Judiciary 
of the House of Representatives. 
SEC. 5553. PROGRAM TO PROVIDE ASSISTANCE TO BUILD THE 
CAPACITY OF FOREIGN LAW ENFORCEMENT AGENCIES 
WITH RESPECT TO COVERED SYNTHETIC DRUGS. 
(a) IN GENERAL.—Notwithstanding section 660 of the Foreign 
Assistance Act of 1961 (22 U.S.C. 2420), the Secretary of State 
shall establish a program to provide assistance to strengthen the 
capacity of law enforcement agencies of the countries described 
in subsection (c) to help such agencies to identify, track, and improve 
their forensics detection capabilities with respect to covered syn-
thetic drugs. 
(b) PRIORITY.—The Secretary of State shall prioritize technical 
assistance, and the provision of equipment, as appropriate, under 
subsection (a) among those countries described in subsection (c) 
in which such assistance and equipment would have the most 
impact in reducing illicit use of covered synthetic drugs in the 
United States.
H. R. 7776—948 
(c) COUNTRIES DESCRIBED.—The foreign countries described in 
this subsection are— 
(1) countries that are producers of covered synthetic drugs; 
(2) countries whose pharmaceutical and chemical industries 
are known to be exploited for development or procurement 
of precursors of covered synthetic drugs; or 
(3) major drug-transit countries for covered synthetic drugs 
as defined by the Secretary of State. 
(d) EXCEPTION.—No assistance may be provided to the People’s 
Republic of China or to any of its law enforcement agencies pursuant 
to the program authorized by this section. 
(e) AUTHORIZATION OF APPROPRIATIONS.—There is authorized 
to be appropriated to the Secretary of State to carry out this 
section $4,000,000 for each of fiscal years 2023 through 2027. 
SEC. 5554. EXCHANGE PROGRAM ON DEMAND REDUCTION MATTERS 
RELATING TO ILLICIT USE OF COVERED SYNTHETIC 
DRUGS. 
(a) IN GENERAL.—The Secretary of State shall establish or 
continue and strengthen, as appropriate, an exchange program 
for governmental and nongovernmental personnel in the United 
States and in foreign countries to provide educational and profes-
sional development on demand reduction matters relating to the 
illicit use of covered synthetic drugs and other drugs. 
(b) PROGRAM REQUIREMENTS.—The program required by sub-
section (a)— 
(1) shall be limited to individuals who have expertise and 
experience in matters described in subsection (a); 
(2) in the case of inbound exchanges, may be carried out 
as part of exchange programs and international visitor pro-
grams administered by the Bureau of Educational and Cultural 
Affairs of the Department of State, including the International 
Visitor Leadership Program, in coordination with the Bureau 
of International Narcotics and Law Enforcement Affairs; and 
(3) shall include outbound exchanges for governmental or 
nongovernmental personnel in the United States. 
(c) AUTHORIZATION OF APPROPRIATIONS.—There is authorized 
to be appropriated to the Secretary of State to carry out this 
section $1,000,000 for each of fiscal years 2023 through 2027. 
SEC. 5555. AMENDMENTS TO INTERNATIONAL NARCOTICS CONTROL 
PROGRAM. 
(a) INTERNATIONAL NARCOTICS CONTROL STRATEGY REPORT.— 
Section 489(a) of the Foreign Assistance Act of 1961 (22 U.S.C. 
2291h(a)) is amended— 
(1) by redesignating the second paragraph (10) as para-
graph (11); and 
(2) by adding at the end the following: 
‘‘(12) COVERED SYNTHETIC DRUGS AND NEW PSYCHOACTIVE 
SUBSTANCES.— 
‘‘(A) COVERED
SYNTHETIC
DRUGS.—Information that 
contains an assessment of the countries significantly 
involved in the manufacture, production, transshipment, 
or trafficking of covered synthetic drugs, to include the 
following: 
‘‘(i) The scale of legal domestic production and 
any available information on the number of manufac-
turers and producers of such drugs in such countries.
H. R. 7776—949 
‘‘(ii) Information on any law enforcement assess-
ments of the scale of illegal production of such drugs, 
including a description of the capacity of illegal labora-
tories to produce such drugs. 
‘‘(iii) The types of inputs used and a description 
of the primary methods of synthesis employed by illegal 
producers of such drugs. 
‘‘(iv) An assessment of the policies of such countries 
to regulate licit manufacture and interdict illicit manu-
facture, diversion, distribution, shipment, and traf-
ficking of such drugs and an assessment of the 
effectiveness of the policies’ implementation. 
‘‘(B) NEW PSYCHOACTIVE SUBSTANCES.—Information on, 
to the extent practicable, any policies of responding to 
new psychoactive substances, to include the following: 
‘‘(i) Which governments have articulated policies 
on scheduling of such substances. 
‘‘(ii) Any data on impacts of such policies and other 
responses to such substances. 
‘‘(iii) An assessment of any policies the United 
States could adopt to improve its response to new 
psychoactive substances. 
‘‘(C) DEFINITIONS.—In this paragraph, the terms ‘cov-
ered synthetic drug’ and ‘new psychoactive substance’ have 
the meaning given those terms in section 5558 of the 
FENTANYL Results Act.’’. 
(b) DEFINITION OF MAJOR ILLICIT DRUG PRODUCING COUNTRY.— 
Section 481(e) of the Foreign Assistance Act of 1961 (22 U.S.C. 
2291(e)) is amended— 
(1) in paragraph (2)— 
(A) in subparagraph (C), by striking ‘‘; or’’ and inserting 
a semicolon; 
(B) in subparagraph (D), by striking the semicolon 
at the end and inserting ‘‘; or’’; and 
(C) by adding at the end the following: 
‘‘(E) that is a significant direct source of covered syn-
thetic drugs or psychotropic drugs or other controlled sub-
stances, including precursor chemicals when those chemi-
cals are used in the production of such drugs and sub-
stances, significantly affecting the United States;’’; 
(2) by amending paragraph (5) to read as follows: 
‘‘(5) the term ‘major drug-transit country’ means a country 
through which are transported covered synthetic drugs or 
psychotropic drugs or other controlled substances significantly 
affecting the United States;’’; 
(3) in paragraph (7), by striking ‘‘; and’’ and inserting 
a semicolon; 
(4) in paragraph (8), by striking the period at the end 
and inserting ‘‘; and’’; and 
(5) by adding at the end the following: 
‘‘(9) the term ‘covered synthetic drug’ has the meaning 
given that term in section 5558 of the FENTANYL Results 
Act.’’. 
SEC. 5556. SENSE OF CONGRESS. 
It is the sense of Congress that—
H. R. 7776—950 
(1) the President should direct the United States Represent-
ative to the United Nations to use the voice, vote, and influence 
of the United States at the United Nations to advocate for 
more transparent assessments of countries by the International 
Narcotics Control Board; and 
(2) bilateral, plurilateral, and multilateral international 
cooperation is essential to combating the trafficking of covered 
synthetic drugs. 
SEC. 5557. RULE OF CONSTRUCTION. 
Nothing in this subtitle or the amendments made by this sub-
title shall be construed to affect the prioritization of extradition 
requests. 
SEC. 5558. DEFINITIONS. 
In this subtitle: 
(1) CONTROLLED SUBSTANCE; CONTROLLED SUBSTANCE ANA-
LOGUE.—The terms ‘‘controlled substance’’ and ‘‘controlled sub-
stance analogue’’ have the meanings given those terms in sec-
tion 102 of the Controlled Substances Act (21 U.S.C. 802). 
(2) COVERED
SYNTHETIC
DRUG.—The term ‘‘covered syn-
thetic drug’’ means— 
(A) a synthetic controlled substance or synthetic con-
trolled substance analogue, including fentanyl or a fentanyl 
analogue; or 
(B) a new psychoactive substance. 
(3) NEW
PSYCHOACTIVE
SUBSTANCE.—The term ‘‘new 
psychoactive substance’’ means a substance of abuse, or any 
preparation thereof, that— 
(A) is not— 
(i) included in any schedule as a controlled sub-
stance under the Controlled Substances Act (21 U.S.C. 
801 et seq.); or 
(ii) controlled by the Single Convention on Narcotic 
Drugs, done at New York March 30, 1961, or the 
Convention on Psychotropic Substances, done at 
Vienna February 21, 1971; 
(B) is new or has reemerged on the illicit market; 
and 
(C) poses a threat to the public health and safety. 
Subtitle D—International Pandemic 
Preparedness 
SEC. 5559. SHORT TITLE. 
This subtitle may be cited as the ‘‘Global Health Security 
and 
International 
Pandemic 
Prevention, 
Preparedness 
and 
Response Act of 2022’’. 
SEC. 5560. DEFINITIONS. 
In this subtitle: 
(1) The term ‘‘appropriate congressional committees’’ 
means— 
(A) the Committee on Foreign Relations of the Senate; 
(B) the Committee on Appropriations of the Senate;
H. R. 7776—951 
(C) the Committee on Foreign Affairs of the House 
of Representatives; and 
(D) the Committee on Appropriations of the House 
of Representatives. 
(2) The terms ‘‘Global Health Security Agenda’’ and 
‘‘GHSA’’ mean the multi-sectoral initiative launched in 2014, 
and renewed in 2018, that brings together countries, regions, 
international organizations, nongovernmental organizations, 
and the private sector— 
(A) to elevate global health security as a national- 
level priority; 
(B) to share best practices; and 
(C) to facilitate national capacity to comply with and 
adhere to— 
(i) the International Health Regulations (2005); 
(ii) the international standards and guidelines 
established by the World Organisation for Animal 
Health; 
(iii) United Nations Security Council Resolution 
1540 (2004); 
(iv) the Convention on the Prohibition of the 
Development, Production and Stockpiling of Bacterio-
logical and Toxin Weapons and on their Destruction, 
done at Washington, London, and Moscow, April 10, 
1972 (commonly referred to as the ‘‘Biological Weapons 
Convention’’); 
(v) the Global Health Security Agenda 2024 
Framework; and 
(vi) other relevant frameworks that contribute to 
global health security. 
(3) The term ‘‘Global Health Security Index’’ means the 
comprehensive assessment and benchmarking of health security 
and related capabilities across the countries that make up 
the States Parties to the International Health Regulations 
(2005). 
(4) The term ‘‘Global Health Security Initiative’’ means 
the informal network of countries and organizations that came 
together in 2001, to undertake concerted global action to 
strengthen public health preparedness and response to chem-
ical, biological, radiological, and nuclear threats, including pan-
demic influenza. 
(5) The term ‘‘IHR (2005) Monitoring and Evaluation 
Framework’’ means the framework through which the World 
Health Organization and the State Parties to the International 
Health Regulations, as amended in 2005, review, measure, 
and assess core country public health capacities and ensure 
mutual accountability for global health security under the Inter-
national Health Regulations (2005), including through the Joint 
External Evaluations, simulation exercises, and after-action 
reviews. 
(6) The term ‘‘Joint External Evaluation’’ means the vol-
untary, collaborative, multi-sectoral process facilitated by the 
World Health Organization— 
(A) to assess country capacity to prevent, detect, and 
rapidly respond to public health risks occurring naturally 
or due to deliberate or accidental events;
H. R. 7776—952 
(B) to assess progress in achieving the targets under 
the International Health Regulations (2005); and 
(C) to recommend priority actions. 
(7) The term ‘‘key stakeholders’’ means actors engaged 
in efforts to advance global health security programs and objec-
tives, including— 
(A) national and local governments in partner coun-
tries; 
(B) other bilateral donors; 
(C) international, regional, and local organizations, 
including private, voluntary, nongovernmental, and civil 
society organizations, including faith-based and indigenous 
organizations; 
(D) international, regional, and local financial institu-
tions; 
(E) representatives of historically marginalized groups, 
including women, youth, and indigenous peoples; 
(F) the private sector, including medical device, tech-
nology, pharmaceutical, manufacturing, logistics, and other 
relevant companies; and 
(G) public and private research and academic institu-
tions. 
(8) The term ‘‘One Health approach’’ means the collabo-
rative, multi-sectoral, and transdisciplinary approach toward 
achieving optimal health outcomes in a manner that recognizes 
the interconnection between people, animals, plants, and their 
shared environment. 
(9) The term ‘‘pandemic preparedness’’ refers to the actions 
taken to establish and sustain the capacity and capabilities 
necessary to rapidly identify, prevent, protect against, and 
respond to the emergence, reemergence, and spread of patho-
gens of pandemic potential. 
(10) The term ‘‘partner country’’ means a foreign country 
in which the relevant Federal departments and agencies are 
implementing United States foreign assistance for global health 
security and pandemic prevention, preparedness, and response 
under this subtitle. 
(11) The term ‘‘relevant Federal departments and agencies’’ 
means any Federal department or agency implementing United 
States policies and programs relevant to the advancement of 
United States global health security and diplomacy overseas, 
which may include— 
(A) the Department of State; 
(B) the United States Agency for International 
Development; 
(C) the Department of Health and Human Services; 
(D) the Department of Defense; 
(E) the Defense Threat Reduction Agency; 
(F) the Millennium Challenge Corporation; 
(G) the Development Finance Corporation; 
(H) the Peace Corps; and 
(I) any other department or agency that the President 
determines to be relevant for these purposes. 
(12) The term ‘‘resilience’’ means the ability of people, 
households, communities, systems, institutions, countries, and 
regions to reduce, mitigate, withstand, adapt to, and quickly 
recover from shocks and stresses in a manner that reduces
H. R. 7776—953 
chronic vulnerability to the emergence, reemergence, and 
spread of pathogens of pandemic potential and facilitates inclu-
sive growth. 
(13) The terms ‘‘respond’’ and ‘‘response’’ mean the actions 
taken to counter an infectious disease. 
(14) The term ‘‘USAID’’ means the United States Agency 
for International Development. 
SEC. 
5561. 
ENHANCING 
THE 
UNITED 
STATES’ 
INTERNATIONAL 
RESPONSE TO PANDEMICS. 
(a) LEVERAGING UNITED STATES BILATERAL GLOBAL HEALTH 
PROGRAMS FOR INTERNATIONAL PANDEMIC RESPONSE.—Subject to 
the notification requirements under section 634A of the Foreign 
Assistance Act of 1961 (22 U.S.C. 2394–1), amounts authorized 
to be appropriated or otherwise made available to carry out section 
104 of the Foreign Assistance Act (22 U.S.C. 2151b) may be used 
in countries receiving such United States foreign assistance for 
the purpose of— 
(1) strengthening vaccine readiness; 
(2) reducing vaccine hesitancy; 
(3) delivering and administering vaccines; 
(4) strengthening health systems and global supply chains 
as necessary for global health security and pandemic prepared-
ness, prevention, and response; 
(5) supporting global health workforce planning, training, 
and management for pandemic preparedness, prevention, and 
response; 
(6) enhancing transparency, quality, and reliability of 
public health data; 
(7) increasing bidirectional testing, including screening for 
symptomatic and asymptomatic cases; and 
(8) building laboratory capacity. 
(b) ROLES OF THE DEPARTMENT OF STATE, USAID, AND THE 
DEPARTMENT OF HEALTH AND HUMAN SERVICES IN INTERNATIONAL 
PANDEMIC RESPONSE.— 
(1) FINDING.—Congress finds that different outbreaks of 
infectious disease threats may require flexibility and changes 
to the designated roles and responsibilities of relevant Federal 
departments and agencies. 
(2) LEAD
AGENCIES
FOR
COORDINATION
OF
THE
UNITED 
STATES’ INTERNATIONAL RESPONSE TO INFECTIOUS DISEASE OUT-
BREAKS WITH SEVERE OR PANDEMIC POTENTIAL.—The President 
shall identify the relevant Federal departments and agencies, 
including the Department of State, USAID, and the Department 
of Health and Human Services (including the Centers for Dis-
ease Control and Prevention), leading specific aspects of the 
United States international operational response to outbreaks 
of emerging high-consequence infectious disease threats in 
accordance with federal law. 
(3) NOTIFICATION.—Not later than 120 days after the date 
of the enactment of this Act, and regularly thereafter as appro-
priate, the President shall notify the appropriate congressional 
committees, the Committee on Health, Education, Labor, and 
Pensions of the Senate, and the Committee on Energy and 
Commerce of the House of Representatives of the roles and 
responsibilities of each relevant Federal department and agency 
with respect to the international operational response to the
H. R. 7776—954 
outbreak of an emerging high-consequence infectious disease 
threat. 
(c) USAID DISASTER SURGE CAPACITY.— 
(1) DISASTER SURGE CAPACITY.—The Administrator of the 
USAID is authorized to expend funds made available to carry 
out part I and chapter 4 of part II of the Foreign Assistance 
Act of 1961 (22 U.S.C. 2151 and 2346), including funds made 
available for ‘‘Assistance for Europe, Eurasia and Central Asia’’, 
in addition to amounts otherwise made available for such pur-
poses, for the cost (including support costs) of individuals 
detailed to or employed by USAID whose primary responsibility 
is to carry out programs to address global health emergencies 
and natural or manmade disasters. 
(2) NOTIFICATION.—Not later than 15 days before making 
funds available to address manmade disasters pursuant to para-
graph (1), the Secretary of State or the Administrator of the 
USAID shall notify the appropriate congressional committees 
of such intended action. 
SEC. 5562. INTERNATIONAL PANDEMIC PREVENTION AND PREPARED-
NESS. 
(a) UNITED STATES INTERNATIONAL ACTIVITIES TO ADVANCE 
GLOBAL
HEALTH
SECURITY
AND
DIPLOMACY
STRATEGY
AND 
REPORT.— 
(1) IN
GENERAL.—The President shall develop, update, 
maintain, and advance a comprehensive strategy for improving 
United States global health security and diplomacy for pan-
demic prevention, preparedness, and response which, consistent 
with the purposes of this subtitle, shall— 
(A) clearly articulate United States policy goals related 
to pandemic prevention, preparedness, and response, 
including through actions to strengthen diplomatic leader-
ship and the effectiveness of United States foreign policy 
and international preparedness assistance for global health 
security through advancement of a One Health approach, 
the Global Health Security Agenda, the International 
Health Regulations (2005), and other relevant frameworks 
that contribute to pandemic prevention and preparedness; 
(B) establish specific and measurable goals, bench-
marks, timetables, performance metrics, and monitoring 
and evaluation plans for United States foreign policy and 
assistance for global health security that promote learning 
and adaptation and reflect international best practices 
relating to global health security, transparency, and 
accountability; 
(C) establish transparent mechanisms to improve 
coordination and avoid duplication of effort between and 
among the relevant Federal departments and agencies, 
partner countries, donor countries, the private sector, 
multilateral organizations, and other key stakeholders; 
(D) prioritize working with partner countries with— 
(i) demonstrated need, as identified through the 
Joint External Evaluation process, the Global Health 
Security 
Index 
classification 
of 
health 
systems, 
national action plans for health security, Global Health 
Security Agenda, other risk-based assessments, and